Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Jurnal Ilmiah Farmasi Jurnal Inovasi Farmasi Indonesia
Qarriy 'Aina Urfiyya
Akademi Farmasi Indonesia Yogyakarta
Decision Sciences, Operations Research & Management Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Analisis biaya pasien Severe Cutaneous Adverse Reactions (SCARs) Qarriy 'Aina Urfiyya; Musa Fitri Fatkhiya; Dyah Aryani Perwitasari; Sri Awalia Febriana; Woro Supadmi
Jurnal Ilmiah Farmasi Vol. 18 No. 2 (2022): Jurnal Ilmiah Farmasi
Publisher : Universitas Islam Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20885/jif.vol18.iss2.art12

Abstract

Background: Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptom (DRESS), were the idiosyncratic reactions most commonly caused by drugs which have an impact on increasing the patient's financial burden. Objectives: This study aims to determine the highest cost component and the illness cost in patients suffering from Severe Cutaneous Adverse Reactions (SCARs). Methods: This study was an analytic observational study with a cross-sectional design. We collected direct medical costs, direct non-medical costs, and indirect costs for inpatients with SJS, TEN, and DRESS at Dr. Sardjito Yogyakarta Hospital from 2014-2018, retrospectively. Based on the societal perspective, we defined the highest cost component and the illness cost in patients with SCARs. Results: The highest cost component for SJS, and TEN patients were obtained in the health professional services (24,1% and 25,2%, respectively). Meanwhile, the highest cost component for DRESS patients was the cost of drugs (20,2%). The total illness cost of 47 SCARs patients (22 SJS patients, 6 TEN patients, and 19 DRESS patients) was IDR 666.615.321, with the highest average cost for TEN patients, followed by SJS and DRESS (IDR 16.510.595, IDR 14.205.545, and IDR 13.445.555, respectively). Conclusions: The highest cost component was the health professional services in SJS and TEN patients and the cost of medicine for DRESS patients. The management of SCARs requires considerable cost, and it is still being a financial burden on the patients.
AN OVERVIEW INSULIN USED IN OUTPATIENT WITH DIABETES MELLITUS TYPE 2 AT HIDAYATULLAH ISLAMIC YOGYAKARTA HOSPITAL Kartika Nur Fahmi; Qarriy 'Aina Urfiyya
Jurnal Inovasi Farmasi Indonesia (JAFI) Vol. 4 No. 1 (2022): Vol. 4 No.1 Desember 2022
Publisher : Universitas Kadiri

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30737/jafi.v4i1.3343

Abstract

Diabetes Mellitus (DM) has a high prevalence and can become a public health problem. The Province of the Special Region of Yogyakarta is included in the top three ranks with DM cases at the age of 15 years, namely 3.1%. The purpose of this study was to determine patient characteristics and descriptions of insulin use in outpatient BPJS patients at Hidayatullah Islamic Hospital Yogyakarta for the period October - December 2021. This study used a descriptive observational design, with retrospective data collection on the medical records of type 2 DM patients BPJS outpatients. This study used purposive sampling technique, a total of 93 medical records. Descriptive data analysis on patient characteristics and insulin use. The result of this study was DM type 2 BPJS outpatients with the highest patient age category was <60 years (53.80%), the highest gender was female (57%), and highest comorbidities was hypertension (68%). The largest therapeutic use was insulin monotherapy (53.76%), with insulin novorapid (74%).
Co-Authors Dyah Aryani Perwitasari Fatkhiya, Musa Fitri Kartika Nur Fahmi Sri Awalia Febriana Woro Supadmi